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Abstract 
Significant progress in the application of viral vectors for gene delivery into mammalian 
cells and the use of viruses as biopesticides requires downstream processing that can satisfy 
application-specific demands on performance. In the present work the stability and ion exchange 
membrane chromatography of a recombinant of Autographa californica M nucleopolyhedrovirus 
is studied. To adjust the degree of purification the effect of ionic conductivity or pH on the viral 
infectivity was assessed (0.77-78.00 mS/cm, pH 3-8). Infectivity decreased rapidly by several 
orders of magnitude at below 5 mS/cm (i.e., 0.49 MPa osmotic pressure change) or at below pH 
5.5 (rationalized with particle aggregation). The virus was concentrated and purified via 
adsorption (0.2-1.1 x 1016 pfu/m3 chromatographic bed volume, 0.6-1.1 x 1012 pfu/m2 membrane 
area facing the incident fluid flow) and elution at pH 6.1 and 6.35 mS/cm from three strong 
anion exchange membranes. Virus recovery and concentration in accord with the volume 
reduction were obtained using a polyether sulfone-based membrane with quaternary ammonium 
ligands. The level of host cell protein (down to below the detection limit) and suspended DNA 
(below 93 pg DNA per 106 pfu) are reported for each membrane employed, for the purpose of 
comparability, under equal adsorption or elution conditions respectively. 
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1. Introduction 
Insect viruses are central components of current manufacturing processes producing 
recombinant proteins such as enzymes (Vicente et al., 2010; Vicente et al., 2009) and human or 
animal vaccines (Justice et al., 2011) at industrial scale (virus cultures in the order of several 
m3/day, Boehringer Ingelheim Vetmedica). For decades large scale applications of biopesticides 
(in the order of 104 km2/year (Moscardi, 1999)) have made use of insect viruses targeting 
specifically their hosts (Mishra, 1998; Moscardi, 1999; Oliveira et al., 2006). This ecologically 
benign response to the increasing demand for agricultural production requires biopesticides that 
can compete economically with conventional chemical pesticides. Thus, a major criterion for 
assessing the value of a biopesticide is its price per infective unit. This is determined 
significantly by the complexity and durability of the downstream manufacturing process of the 
viral pesticide. On the other hand, highly purified insect viruses are employed as viral vectors in 
the clinical development of vaccines, e.g., for lymphoma patients (Betting et al., 2009). 
Similarly, academic research studying, e.g., the underpinnings of viral pathogenesis (Goley et al., 
2006) utilize ultrapure viral dispersions with minimum DNA and host cell protein levels. 
Baculoviruses have been applied globally for control of Lepidoptera pests, e.g., in 
soybean and cotton crops (Moscardi, 1999) and have been studied as a vector for gene therapy 
(Liang et al., 2003; Long et al., 2006). In 2009 the FDA approved Cervarix (GlaxoSmithKline-
Biologicals), a vaccine against two main types of cancer-causing human papillomavirus 
produced with the Baculovirus Expression System (Betting et al., 2009). A baculovirus used 
commonly for biopesticide production and for expression of recombinant proteins, Autographa 
californica M nucleopolyhedrovirus (AcMNPV), is an enveloped dsDNA virus infectious for 
lepidopteran insects. AcMNPV exists in two forms, budded virus and occluded virus. The rod-
shaped budded virus (approximately 15 to 40 nm x 200 to 300 nm in size) is assembled in the 
first phase of infection. This virus form contains a single nucleocapsid surrounded by an 
envelope obtained from the host cell plasma membrane when the virus is released from infected 
cells into the surrounding medium (Ihalainen et al., 2009; O’Reilly, 1994; Rohrmann, 1992). 
Various methods for virus concentration and purification exist (for a thorough review of 
state of the art bioprocessing of baculoviruses see (Aucoin et al., 2010)). At small scale viruses 
can be concentrated and purified via sucrose density centrifugation. This results in low 
production rates and low yields but high purity virus dispersions (Aboud et al., 1982; Aranha, 
2001). At large scale, virus membrane filtration represents a beneficial trade-off. Membrane-
based filtration can process potentially large volumes, yielding high virus concentrations and 
recovering infectivity and membrane performance on one hand. The purity of the viral product 
on the other hand can be tuned if the membrane is equipped with an electric charge carrier. 
Given the broad range of applications for AcMPNV in industry and research and 
development, membrane-based filtration of AcMPNV has received great interest in the past. This 
includes the use of ultrafiltration membranes, ion exchange membranes and resin-based 
chromatography (Barsoum, 1999; Michalsky et al., 2009; Transfiguracion et al., 2011; Wu et al., 
2007). However, the purification of AcMPNV is developed poorly (Vicente et al., 2010; Vicente 
et al., 2009) and materials and processes for the efficient downstream processing of 
baculoviruses for clinical applications is sought (Vicente et al., 2010; Vicente et al., 2009). 
In general, adsorptive membranes have been studied as an alternative to conventional 
resin-based chromatography columns (Ghosh, 2002; Klein, 2000). Adsorptive membranes 
benefit from shorter diffusion times (i.e., mass-transfer of the molecule of interest to and from 
the active sites on the membrane or resin) relative to those obtained with resin-based 
chromatography (Barsoum, 1999). This may reduce significantly the size and cost of unit 
operations for the industrial-scale downstream processing of virus dispersions. Ion exchange 
membrane chromatography (IEMC) is based on adsorptive membranes that employ the electric 
interaction between charged components of a liquid phase (e.g., viruses) and ionic groups 
immobilized on the solid membrane matrix. This is a conceivably simple and efficient method 
for virus concentration and purification. In contrast to sucrose density centrifugation, aggregation 
of viral particles and loss of viral activity due to hydrodynamic shear stress are decreased by the 
use of ion exchange chromatography (Barsoum, 1999). Compared to conventional resin-based 
chromatography, IEMC shows relatively high capacities for biological macromolecules and a 
decreased sensitivity to flow rates affecting product yield and purity (Yang et al., 2002). 
Previous studies have addressed the physical stability (Jorio et al., 2006a; Oliveira et al., 
2006) of a recombinant of AcMNPV (Michalsky et al., 2008) and have assessed simple virus 
concentration via tangential ultrafiltration with commercial polysulfone membranes (Michalsky 
et al., 2009; Wu et al., 2007). Based on this work, a comparison of three different adsorptive 
membranes for concentration and purification of a recombinant of AcMNPV is provided here. To 
control product purity, yield and recovery of infectivity, the feasible range for adjusting the ionic 
conductivity or the pH during IEMC-based filtration of AcMNPV was determined. Thereafter, 
virus filtration experiments were conducted under conditions (non-isoelectric elution at increased 
ionic conductivity) aiming for a maximum viral product yield rather than product purity. Three 
strong anion exchange membranes (cellulose or polyether sulfone membranes with functional 
quaternary ammonium groups or polyethylene membranes coated with poly(allylamine)) were 
utilized for separation of AcMNPV from crude cell culture media. Recovery and maximum 
concentration of infectivity are reported along with diminished host cell protein and suspended 
DNA levels. 
2. Materials and Methods 
2.1 Cells and virus 
Cells of the IPLB-SF21-AE (SF-21) cell line adapted to Sf-900 II Serum Free Medium 
(SFMII) (Invitrogen) were grown in SFMII (pH 6.1, 0.36 osmol/kg) (Invitrogen) at 27 °C using 
Erlenmeyer flasks rotated at 100 rpm (H+P Labortechnik). Cell cultures were passaged twice a 
week as described previously (O’Reilly et al., 1994). 
A recombinant of AcMNPV, vHSGFP containing the enhanced green fluorescent protein 
gene (egfp) controlled by the Drosophila heat shock protein 70 (hsp70) promoter has been 
described elsewhere (Clarke and Clem, 2002) and was used here for virus cultivations. The virus 
was a gift from Professor A. Lorena Passarelli, Division of Biology, Kansas State University, 
Manhattan, KS, USA. To obtain a virus stock SF-21 cultures were infected with vHSGFP at a 
multiplicity of infection (MOI) of 0.1 plaque forming units per cell (pfu/cell). The budded virus 
in the supernatant was harvested 5 days post infection by centrifugation (1000 x g, 10 min, at 
room temperature), and stored in the dark at 4 °C in polypropylene bottles (Jarvis et al., 1994; 
Jorio et al., 2006a; O’Reilly, 1994). 
2.2 Virus infectivity 
TCID50 endpoint dilution was used to determine virus infectivity in pfu/ml (with an error 
of ca. 0.5 orders of magnitude (O’Reilly, 1994; Roldão et al., 2009)) as described previously. 
Briefly, SF-21 cells (105 cells/ml) aliquoted on 96-well cell culture dishes (Greiner Bio One) 
were infected with virus dilutions ranging from 10-1 to 10-10 pfu/ml. Infectious virus was 
determined by counting wells containing infected cells identified by green fluorescence at 5 days 
post infection (Wilovert AFL 20 microscope, Sybrgreen fluorescence emission filter, Hund 
GmbH). 
2.3 Protein analysis 
Protein concentrations were determined using the Bradford assay (80 µl sample mixed 
with 20 µl Bradford reagent containing 0.5 mg/ml coomassie blue, 25 vol% ethanol, 42.5 vol% 
orthophosphoric acid and 32.5 vol% H2O). Samples were incubated in absence of light for 
15 min on 96-well cell culture dishes (Greiner Bio One). A linear calibration (R2 > 0.988) using 
0.1 to 1.0 mg/ml bovine serum albumin standards was used to estimate protein concentrations of 
samples detected for absorbance at 595 nm (Synergy HT Multimode-Reader, Biotek).  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using the TV-
50 Vertical Electrophoresis Chamber (Fisherbrand) was utilized to validate the degree of virus 
purification. Samples taken from the washing (Fraction 4 and 9) and elution step (Fraction 11 
and 14) were diluted 4:1 in NuPAGE® LDS Sample Buffer (4X), incubated for 10 min at 95 °C, 
and thereafter loaded (together with 1:4 dilutions of virus dispersion before purification) into a 
NuPAGE® 4-12% Bis Tris Gel (Invitrogen). After separation (200 V, ice bath) the gel was 
stained using the Pierce ® Silver Stain Kit (Thermo Scientific). 
2.4 DNA quantification 
The suspended DNA level in all viral dispersions before and after filtration experiments 
was determined with Sybr Green I (0.5 mg/ml) at 488 nm excitation wavelength and 528 nm 
emission wavelength (Sigma-Aldrich). The assay was calibrated in a linear range (R2 > 0.999) 
from 1.0 x 10-11 to 1.3 x 10-3 g/ml deoxyribonucleic acid (calf thymus standard). Samples were 
incubated in absence of light for 5 min on 96-well cell culture dishes (Greiner Bio One). 
Fluorescence was measured with the Synergy HT Multimode-Reader (Biotek). 
2.5 Virus stability 
To test for virus inactivation due to elution of the virus from the membrane, the effect of 
pH on infectivity in harvested virus dispersions was assessed. The pH (SG8-SevenGo pro™ 
pH/Ion; Mettler Toledo) of harvested virus dispersion (ca. pH 6) was adjusted in the range of pH 
3.0-8.0 using 1 mol/l HCl or 1 mol/l NaOH respectively. To correlate virus infectivity and virus 
particle aggregation, virus infectivity and absorption at 595 nm (multifunction plate reader, 
Synergy HT Multimode-Reader, Biotek) was detected in 40 aliquots (1 ml) taken from the virus 
dispersion with step-wise adjusted pH values. 
To study the effect of a sudden change of ionic conductivity (κ) on virus infectivity κ 
(measured with SG8-SevenGo pro™ pH/Ion; Mettler Toledo) of harvested virus dispersion 
(8.1 ± 0.4 mS/cm, i.e., ionic strength of 0.360 ± 0.007 osmol/kg) was adjusted in the range of 
0.77 to 78.00 mS/cm (i.e., 0.16 ± 0.02 to 0.77 ± 0.01 osmol/kg) with NaCl or deionised water 
respectively. Virus infectivity was detected in 13 samples (10 ml) at 0 and 24 h (stored in the 
dark at 4 °C). Osmolality was measured utilizing the Osmometer Typ 6 (Löser Messtechnik). 
2.6 Ion exchange membrane chromatography 
To assess the applicability of strong anion exchange membranes for concentration and 
purification of AcMNPV’s budded virus cellulose-based (4.6 x 10-7 m3 chromatographic bed 
volume, Sartobind Q, Sartorius, SQ) and polyether sulfone-based adsorptive membranes (5.4 x 
10-7 m3 chromatographic bed volume, Mustang Q, Pall, MQ) with quaternary ammonium 
functional groups (both 5.48 x 10-4 m2 fluid inflow cross-section area per membrane layer, 3 
membrane layers used) were tested (membrane holder from Schüller & Schnell) (Fig. 1). 
Additionally, performance of an ultra-high weight polyethylene-based adsorptive membrane 
coated with poly(allylamine) (8.0 x 10-8 m3 bed volume, 1.00 x 10-4 m2 fluid inflow cross-section 
area per membrane layer, 8 membrane layers used, ChromaSrob, Millipore, CS) was studied. 
Membranes were equilibrated for 10 min with 10 ml 20 mmol/l Tris buffer (pH 6.5) and 
loaded with 3 ml virus dispersion ((3.4 ± 1.2) x 108 pfu/ml) (Pharmacia LKB peristaltic pump P1, 
Thermo Scientific; Pharmamed® BPT silicon hose, Saint Gobain Performance Plastic 
Cooperation). After washing with 6 ml 20 mmol/l Tris buffer virus was eluted with 3 ml 
0.15 mol/l NaCl followed by 3 ml 0.5 mol/l NaCl. All liquid flow rates were 1 ml/min at 
approximately 25 °C. The eluate was fractionated into 1 ml aliquots for analysis.  
2.7 Chemicals 
HCL (aqueous solution, 37 wt%), NaOH (pellets, ≥ 98.0 wt%) and NaCl (powder, ≥ 99.5 
wt%) were from Merck. Coomassie blue and orthophosphoric acid (85 wt%), were purchased 
from AppliChem. Tris buffer, bovine serum albumin (cell culture grade) and ethanol (98 wt%) 
were from Sigma Aldrich. Water was deionised using the Milli-Q Academic water purification 
system (Millipore). 
3. Results 
3.1 The effect of pH and ionic conductivity on viral infectivity 
Infectivity decreased 3 orders of magnitude from (7.9 ± 5.7) x 106 pfu/ml at pH 6.0 ± 0.3 
to (6.6 ± 0.7) x 103 pfu/ml at pH 4.9 ± 0.3. Decrease of viral infectivity was accompanied by an 
increase of light absorption (Fig. 2). The virus titer was under the detection limit when the pH 
was further decreased to pH 3. In the same pH range light absorbance reached a local maximum 
at ca. pH 4.1 ± 0.3. Particle sedimentation was not observed. Increasing the pH from 6 to 8 did 
not change the virus titer significantly but increased light absorbance at pH 8. 
Virus infectivity decreased approximately 3 orders of magnitude from (2.5 ± 1.2) x 106 
pfu/ml at 8.1 ± 0.4 mS/cm to (5.9 ± 2.9) x 103 pfu/ml at 1.20 ± 0.02 mS/cm (Fig. 3). The effect 
was instantaneous and storage for 24 h at 4 °C did not alter significantly infectivity. Simple 
dilution of virus dispersions (1:20) when decreasing κ to 0.77 ± 0.01 mS/cm yielded 
(1.9 ± 1.0) x 104 pfu/ml and thus does not explain entirely the decreased infectivity observed. 
Infectivity was below detection limits at κ < 0.77 mS/cm (data not shown). In the range of 10-20 
mS/cm the change in infectivity did not exceed the detection uncertainty. Opposing results 
obtained at low κ, infectivity of virus dispersions at > 15 mS/cm decreased instantaneously by 
ca. 1 order of magnitude and thereafter slowly by a total of ca. 3 orders of magnitude after 24 h. 
3.2 Virus concentration via ion exchange membrane chromatography 
Dispersions of a recombinant of AcMNPV (3 ml) were loaded (fraction 1 to 3) onto 
strong anion exchange membranes (Fig. 4). The membranes were washed subsequently with 
6 ml buffer (fraction 4 to 9), flushed with 3 ml elution buffer at 0.15 mol/l NaCl (fraction 10 to 
12) and 3 ml 0.5 mol/l NaCl (fraction 13 to 15) (Fig. 1). Of the (3.4 ± 1.7) x 108 pfu/ml loaded 
ca. 98.4 %, 99.0 %, or 89.4 % were adsorbed by the MQ, SQ, or CS membranes after washing 
respectively. Washing the membranes eluted minor amounts of infectious virus (1.0 % (MQ), 
0.7 % (SQ), or 5.8 % (CS)) perhaps due to reduced particle-membrane interaction when reaching 
the binding capacity of the membrane material. Apparent binding capacities (defined as 
infectious virus in pfu absorbed by the chromatographic bed volume in m3 after flushing with 
buffer) were determined based on a balance of infectious particles (Table 1). 
Flushing the membranes with 0.15 mol/l NaCl yielded only minor amounts of virus in the 
eluate (Fig. 4). Elution with 0.5 mol/l NaCl yielded viral titer of (1.1 ± 0.5) x 109 pfu/ml (MQ, 
Fig. 4A), (4.8 ± 1.2) x 108 pfu/ml (SQ, Fig. 4B), or (1.4 ± 0.9) x 104 pfu/ml (CS, Fig. 4C), that is 
concentration of infectious virus by a factor of ca. 1.4 (SQ) to 3.3 (MQ). Regarding the CS 
membrane, > 99.99 % of the virus adsorbed was bound irreversibly (assuming that the fraction of 
virus remaining on the membrane after elution closes the balance of infectious particles). 
3.3 Virus purification 
From approximately 0.13 ± 0.01 mg protein suspended per ml harvested virus dispersion 
ca. 30.3 wt%, 64.6 wt%, or 70.6 wt% were adsorbed by the MQ, SQ, or CS membranes after 
washing with Tris buffer respectively (Fig. 4). This relates to binding of host cell protein (HCP) 
in kg HCP per m3 chromatographic bed volume of (0.24 ± 0.03) kg/m3 (MQ), (0.50 ± 0.03) 
kg/m3 (SQ), and (3.44 ± 0.01) kg/m3 (CS). After elution of the virus from the membrane material 
HCP in fraction 14 decreased by a factor of 7.62 x 10-4 g/g (SQ), or 5.97 x 10-2 g/g (CS). HCP 
concentrations were below the detection limit when using the MQ membrane material. 
SDS-PAGE analysis shows that the first fraction of the washing step (fraction 4) using 
any of the tested membrane materials contains proteins with a molar mass below 30 kDa (Fig.5). 
Protein concentrations at the final stage of the washing step (fraction 9) and the first elution step 
(fraction 11) are below the detection limited. The analysis of the second elution step (fraction 14) 
yields protein bands correlating with the virus-specific GP64 surface protein (64 kDa) when 
employing the MQ and SQ membrane. Fraction 14 taken from the filtration using the CS 
membrane materials does not exhibit a virus-specific band. 
IEMC decreased the levels of DNA that is suspended freely in the virus dispersions 
(compare 2.6) from 674 ± 35 ng/ml (harvested virus dispersion) to ca. (95 ± 5) ng/ml (MQ), (154 
± 8) ng/ml (SQ) or (6.2 ± 0.3) ng/ml (CS) detected at maximum in the eluted fractions 
respectively (Fig. 6). This relates to a reduction of approximately 85.9 wt% (MQ), 77.1 wt% 
(SQ), or 99.1 wt% (CS) maximum DNA concentration in the eluate relative to the DNA level 
detected in harvested virus dispersion respectively.  
4. Discussion 
4.1 Parameters to control the downstream processing 
The pH and/or the ionic conductivity in the eluate may be utilized to control the product 
purity, yield and recovery of infectivity of a virus dispersion during IEMC. In principle, 
infectivity of viral dispersions was maintained essentially constant in the range of pH 6-8 and 8-
15 mS/cm (Fig. 2 and 3). Based on the stability testing (see section 3.1) the ionic conductivity 
may be adjusted for a short time in the range of 15-80 mS/cm if the primary goal of the 
downstream process is high purity rather than high recovered infectivity (see 4.1.2 and 5.). 
4.1.1 Net-surface charge of the virus particle and aggregation 
Approaching the isoelectric point of a macromolecule (carrying a net negative surface 
charge when dispersed in a pH-neutral aqueous phase) at decreased pH values decreases the 
repulsive forces between single macromolecules. This may support particle aggregation due to 
hydrogen bonding. Enveloped viruses are known to be sensitive to low H3O+ activities (Gaudin 
et al., 1995). Also, pH changes resulting in virus particle aggregation have been correlated 
previously with decreased baculovirus infectivity (Jorio et al., 2006b). 
The literature reports the isoelectric point of various baculoviruses in the range of pH 4 to 
6. The isoelectric point of the CMV-Luc baculovirus has been estimated at pH 5.4 (Yang et al., 
2009). Based on flow cytometry experiments, Jorio et al. demonstrated aggregation of 
AcMNPV’s budded virus accompanied by an infectivity loss at pH 5.3. Using theory and 
dynamic light scattering experiments a minimum ζ-potential of an AcMNPV dispersion has been 
estimated in the range of pH 4-6 (at ca. 4.7) (Vicente et al., 2010). 
Increased light absorbance commencing between pH 4-6 (Fig. 2, see 3.1) is evidence for 
aggregation of viral particles, cell debris or proteins in dispersion. Maximum light absorbance 
and infectivity decreased by ca. 3 orders of magnitude at 25 °C was detected at pH 4.1 ± 0.3. 
This may be rationalized with aggregation of viral particles due to a minimized electrostatic 
surface potential. Similarly, resolved aggregation of viral particles with an irreversible loss in 
viral infectivity may be hypothesized when further decreasing the H3O+ activity to pH 3. 
Increased light absorbance and stable infectivity at pH 8.0 ± 0.2 may be due to aggregation of 
cell debris and HCP. As a major conclusion, the experimental results presented support the 
evidence for an isoelectric point of the recombinant of AcMPNV tested near pH 4.1 ± 0.3. 
4.1.2 Virus particle stability and osmotic pressure 
Low ionic conductivity in virus dispersions resulting in decreased infectivity (see 3.1) has 
been linked previously to an increased osmotic pressure, e.g., for the enveloped Sindbis virus 
(Waite et al., 1968). To estimate the related change in osmotic pressure the following assumes a 
dilute and incompressible liquid phase and a negligible total virus plasma volume (vp) compared 
to the volume of the virus dispersion (vd). Thus, the absolute osmotic pressure (π) gradient 
(Prausnitz et al., 1999) over the viral membrane after the addition of salt reduced by the osmotic 
pressure gradient before the addition of salt (δπabs) can be written as: 
(1)     j
j
j
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
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where R is the gas constant in J/K/mol, T is the liquid temperature in K, and νd in m3/kg is the 
specific volume (approximated with water at ambient conditions) available to ijnj mol osmotic 
active ions (determined analytically) in osmol/kg H2O. 
 The infectivity of the virus dispersion increased slightly when κ increased from 8.1 to 10-
20 mS/cm (i.e., addition of 0.05-0.10 mol/l NaCl increasing presumably the water flux from the 
virus particle into the surrounding medium). Decreasing κ to 5 mS/cm (δπabs = 0.49 ± 0.07 MPa) 
inactivated instantaneously the major fraction of the dispersed virus. This may be contributed to 
a rapidly increased water flux from the surrounding liquid phase into the virus particle. Similarly, 
Chen et al. reported stable infectivity of a recombinant baculovirus (AcVSVG-CAGFP dispersed 
in 20 mmol/l Tris buffer with an addition of PBS) when adding NaCl in the range of 0.1 to 0.3 
mol/l (i.e., ca. 4.2-6.7 mS/cm). At lower salt concentrations infectivity decreased (Chen et al., 
2009). Increasing κ to 25 mS/cm (δπabs = 1.00 ± 0.03 MPa) inactivated the major fraction of 
AcMNPV in dispersion after 24 h. The time required for virus inactivation at increased ionic 
conductivity may point towards a relatively slow water flux from the virus particle into the 
surrounding medium resulting in temporality stable virus dispersions at increased κ. 
In summary, the recombinant of AcMNPV appears to maintain long-term infectivity 
when increasing the water flux from the virus particle to the surrounding medium at δπabs < 1. 
Infectivity is reduced slowly when further increasing this pressure. The virus is inactivated 
instantaneously when reversing the direction of the osmotic pressure (water flux from the 
surrounding liquid phase into the virus particle). 
4.2 Virus concentration via IEMC 
Three strong anion exchange membranes were tested for concentration and purification 
of AcMNPV. Aiming for comparable process conditions, all membranes were tested under equal 
adsorption, washing, and elution conditions. Concentration results may alter when optimizing 
these conditions for each membrane material separately. This section discusses recovery and 
concentration of infectivity (see 3.2, Fig. 4, Fig.5, and Table 1). Purification with respect to HCP 
and DNA levels is discussed in section 4.3. 
4.2.1 Virus adsorption 
Approaching the break-through (significant infectivity detected in the fraction 3) ensures 
that binding capacities reported here (Table 1) reflect approximately the total capacities of the 
tested materials. The high capacity of the CS membrane for AcMNPV’s budded virus is likely 
due to a relative small bed volume employed causing an early and complete break-through of 
viral particles (Fig. 4). Lower total binding capacities of the MQ and SQ membranes compared 
to the CS membrane can thus not be inferred unerringly. For comparison, binding capacities for 
other viruses to strong anion exchange membranes have been reported previously in a similar 
range (Han et al., 2005; Kutner et al., 2009; Woo et al., 2011; Wu et al., 2007). 
4.2.2 Virus elution 
Data from at least two experiments (using the MQ or SQ material respectively) support 
successful maintenance of infectivity when exposing virus dispersions for < 1 h to an increased 
ionic conductivity. Furthermore, IEMC using the MQ membrane yielded a virus concentration 
factor in accord with the volume reduction allowing a theoretical concentration by a factor of 
three. In the future this may be further increased, e.g., by decreasing the eluate volume or 
optimizing the trans-membrane flux during the adsorption step.  
High virus recovery and efficient concentration distinguish the cellulose- or polyether 
sulfone-based membranes with quaternary ammonium ligands (SQ or MQ) as applicable 
materials for mild, scalable, and economically attractive virus concentration, e.g., for the 
production of biopesticides (see 1.). The SDS-PAGE confirms virus concentration qualitatively 
using these materials (Fig.5). Given the irreversible binding of AcMPNV particles to the CS 
membrane at the tested conditions, poly(allylamine)-coated polyethylene membranes may be 
used as a simple and efficient part of viral de-concentration processes. Alternatively, these 
membranes may be utilized for the purification of proteins carrying a net positive surface charge. 
4.3 Virus purification 
Elution experiments were conducted under non-isoelectric conditions (pH 6.1) aiming for 
a maximum viral product yield rather than for maximum product purity. For comparability, all 
membranes were tested under equal elution conditions. That is purification results may be 
increased by optimizing elution conditions for each membrane material separately.  
All tested membrane materials decreased the HCP concentration significantly, up to 
below the detection limit using the MQ membrane (see 3.3). The SDS-PAGE confirms 
qualitatively decreased HCP concentrations for all three membrane materials (Fig.5). With 
regard to allergenic proteins which may be contained in baculovirus suspensions, such as 
glycoprotein (Heimpel et al., 1967), this could be advantageous when considering clinical 
applications of the virus studied here. 
Furthermore, about 28.3 wt% (MQ), 54.8 wt% (SQ) or 59.8 wt% (CS) of HCP relative to 
the total HCP present in the virus dispersion processed bound irreversibly to the membrane. This 
assumes that irreversible binding of HCP can be estimated by the difference between the HCP 
contained in the total volume of virus dispersion filtered and the HCP recovered in all samples 
collected. This together with maximum binding capacities of up to 30 mg bovine serum albumin 
per ml (manufacturer certificate) point out the possibility to recycle the tested membranes 
without the need for additional chemicals introduced into the process. Based on the experimental 
results reported here the MQ material appears most promising for reduction of HCP.  
IEMC decreased the concentration of free DNA by 77.1-99.1 wt% (Fig. 6). During the 
course of the filtration experiments, a small amount of DNA adsorbed to the membranes, relative 
to the adsorbed protein fractions (Fig. 4 and 6). Washing or elution at 0.5 mol/l NaCl eluted 
quickly a major fraction of the adsorbed DNA from the MQ and SQ materials. The remainder, 
33.3 wt% (MQ), 30.5 wt% (SQ), or 31.5 wt% respectively, may be assumed to have bound 
irreversibly to the membranes. This suggests relative weak interactions between the DNA and 
the membrane materials, compared to the interactions of suspended protein. The MQ and SQ 
materials in particular can be regenerated with increased salt concentrations. 
The potential risk arising from DNA impurities in virus samples for clinical applications 
has to be weighed on a case-by-case basis (FDA, 1997; ICH, 1996; WHO, 1998). In general, the 
potential risk associated with baculoviral DNA or DNA arising from an insect cell line has been 
deemed previously as low relative to potentially allergenic protein, such as glycoprotein (see 
above, this section) (Heimpel et al., 1967). However, assuming a single clinical dose containing 
a total of 106 active vectors yields theoretically about 93 pg/dose, i.e., when using the MQ 
material for virus concentration and purification (maximum DNA level in the eluate relative to 
the concentrated infectivity, based on the DNA reduction and virus concentration factors 
estimated at 3.3, and 3.2, or 4.2.2 respectively). This would be sufficiently low to confirm with 
FDA guidelines suggesting an application-specific maximum of ca. 100 pg/dose (FDA, 1997; 
ICH, 1996; WHO, 1998). If lower active vector levels would suffice the specific application than 
the SQ material may decrease free DNA to the desired level as well, e.g., 32 pg DNA per 105 
pfu. 
5. Conclusions 
Ion exchange membrane chromatography may be used for virus downstream processing 
at large scale yielding high concentrations of recovered infectivity or high product purity 
dependent on the choice of process parameters. To guide this choice for the separation of a 
recombinant of AcMNPV virus stability dependent on pH and ionic conductivity was assessed 
(see 4.1). Results support the evidence for an isoelectric point of the budded virus (see 4.1.1) and 
provide a semi-quantitative kinetic study of the relation between ionic conductivity, osmotic 
pressure, and viral infectivity (see 4.1.2). 
Concentration and purification of the virus in a single process step using strong anion 
exchange membranes were demonstrated under comparable process conditions. Optimization of 
these conditions for a given membrane material may advance the process performance. A 
maximum virus concentration factor was obtained with a polyether sulfone-based membrane 
carrying quaternary ammonium functional groups (see 4.2). Impurities arising from host cell 
protein could be decreased below the detection limit using this material. Also, filtration with 
membranes carrying quaternary ammonium functional groups could diminish the level of 
suspended DNA to below 100 pg per 105 to 106 pfu (see 4.3). 
Aiming for maximum product purity, future work may explore ion exchange membrane 
chromatography employing rapid and selective elution of the virus near its isoelectric point. This 
may require means to prevent or reverse aggregation. Alternatively, an increased recovery of 
infectivity when increasing salt concentrations in the eluate and short-term maintenance of 
infectivity at these conditions outlines the possibility of to increase separation efficiencies at 
increased salt concentrations. 
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Tables 
 
IEMC    
Material 
 adsorbed virus a 
(pfu / m³ bed volume) (pfu / m² inflow area) 
     
MQ (2.01 ± 1.01) x 1015  (1.98 ± 1.00) x 1012 
SQ (2.03 ± 1.00) x 1015 (1.70 ± 0.84) x 1012 
CS (1.14 ± 0.64) x 1016 (9.12 ± 5.12) x 1012 
     
 desorbed virus a 
 (pfu / m³ bed volume) (pfu / m² inflow area) 
     
MQ  (2.28 ± 0.29) x 1015 (2.25 ± 0.29) x 1012 
SQ (1.81 ± 0.14) x 1015 (1.52 ± 0.12) x 1012 
CS  (2.31 ± 0.05) x 1011 (1.85 ± 0.04) x 108 
 
Table 1: Apparent binding capacities of a recombinant baculovirus of AcMNPV purified 
using three different strong anion exchange membranes (see 2.6); a, data are given as infectivity 
relative to the chromatographic bed volume or relative to the membrane area facing the incident 
fluid flow (area intersecting the flow per layer times number of layers utilized) respectively. 
Figures 
Figure 1: Schematic setup of virus production and one-step virus concentration and 
purification. 
Figure 2: Infectivity of virus dispersions and absorbance at 595 nm vs. pH. A line was 
added to guide the eye. Error bars are one standard deviation. 
Figure 3: Infectivity (instantaneously or after 24 h storage) vs. ionic conductivity in the 
liquid phase. Lines were added to guide the eye. Error bars reflect the average uncertainty 
reported previously for the assay quantifying viral infectivity (see 2.2). 
Figure 4: Separation of AcMNPV using three different anion exchange membranes. All 
fractions are 1 ml. Eluate I contains 0.15 mol/l NaCl, eluate II contains 0.5 mol/l NaCl. The 
acronyms of the tested membrane materials are given at 2.6. Error bars are one standard 
deviation for samples analyzed in triplicate. 
Figure 5: SDS-PAGE analysis for a relative comparison of protein present in AcMNPV 
dispersions purified by three different adoptive membranes (MQ, SQ, or CS): The initial and 
final fraction of the washing step (fraction 4 and 9) on the left and samples from the first (150 
mM/L NaCl) and second (500 mM/L NaCl) elution step (fraction 11 and 14) on the right. Bands 
correlating presumably with the virus-specific GP64 are marked (arrow).  
Figure 6: Concentration of total suspended DNA during the course of three filtration 
experiments (acronyms of the tested membrane materials are given at 2.6). The DNA level of 
harvested virus dispersion was 674 ± 35 ng/ml. The Relative standard deviation of five-fold 
repeated measurements is 5.22 % (95.4 % confidence interval). 
